Procalcitonin in children with sepsis and septic shock;Procalcitonina em crianças com sepse e choque séptico

Jornal de Pediatria

Volumn 83, Issue 4, 2007, Pages 323-328

  Fioretto, José R ^a   De Borin, Fernanda C ^a   Bonatto, Rossano C ^a   Ricchetti, Sandra M Q ^a   Kurokawa, Cilmery S ^a   De Moraes, Marcos A ^a   Carpi, Mário F ^a   Padovani, Carlos R ^a   Martin, Joelma G ^a,b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b Hospital das Clínicas HC   (Brazil)

Author keywords

Children; Intensive care; Procalcitonin; Sepsis; Septic shock

Indexed keywords

PROCALCITONIN;

ADOLESCENT; ARTICLE; BACTERIAL INFECTION; CHILD; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MYCOSIS; NEWBORN; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADOLESCENT; BIOLOGICAL MARKERS; CALCITONIN; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; MALE; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SEPSIS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TIME FACTORS;

EID: 34548222140     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1644     Document Type: Article

References (23)

1. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29(7 Suppl):S109-16.
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864-74.
3. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-6.
4. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care. 2005;11:473-80.
5. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem. 2001;38(Pt 5):483-93.
6. Meisner M. Biochemistry. In: Meisner M, ed. Procalcitonin (PCT): a new, innovative infection parameter. Biochemical and clinical aspects. Stuttgard: Georg Thieme Verlag; 2000. p. 15-45.
7. Carrol ED, Thomson APJ, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002;20:1-9.
8. Casado-Flores J, Blacon-Quirós A, Asensio J, Arranz E, Garrote JA, Nieto M. Serum procalcitonin in children with suspected sepsis: a comparison with C-proteitn and neutrophil count. Pediatr Crit Care Med. 2003;4:190-5.
9. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27:498-504.
10. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet. 1998;351:1211-2.
11. Carcillo JA, Fields AI; Comitê de Força-Tarefa. Parâmetros de prática clínica para suporte hemodinâmico a pacientes pediátricos e neonatais em choque séptico. J Pediatr (Rio J). 2002;78:449-66.
12. Wilkinson JD, Pollack MM, Glass NL, Kanter RK, Katz RW, Steinhart CM. Mortality associated with multiple organ system failure and sepsis in pediatric intensive care unit. J Pediatr. 1987;111:324-8.
13. Pollack MM, Ruttimann EU, Getson PR. Pediatric risk of mortality (PRISM) score. Crit Care Med. 1988;16:1110-6.
14. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858-73.
15. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004;39:206-17.
16. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leukocyte count. Arch Dis Child. 1999;81:417-21.
17. Enguix A, Rey C, Concha A, Medina A, Coto D, Dieguez MA. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children. Intensive Care Med. 2001;27:211-5.
18. Carrol ED, Newland P, Thomson AP, Hart CA. Prognostic value of procalcitonin in children with meningococcal sepsis. Crit Care Med. 2005;33:224-5.
19. Resch B, Gusenleitner W, Muller WD. Procalcitonin and interleukin-6 in the diagnosis of early-onset sepsis of the neonate. Acta Paediatr. 2003;92:243-5.
20. Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly. 2001;131:595-602.
21. Luzzani A, Polati E, Dorizzi R, Rungatscher A, Pavan R, Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit Care Med. 2003;31:1737-41.
22. Assicot M, Gendrel D, Carsin H, Raymond J, Guilband J, Bohuon C. High serum procalcitonin in patients with sepsis and infection. Lancet. 1993;341:515-8.
23. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 1998;24:888-9.